title: Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.
abstract: Gene therapy with viral vectors is one of the most promising strategies for sensorineural hearing loss. However, safe and effective administration of the viral vector into cochlear tissue is difficult because of the anatomical isolation of the cochlea. We investigated the efficiency and safety of round window membrane (RWM) application of Sendai virus, one of the most promising non-genotoxic vectors, after pretreatment with hyaluronic acid (HA) on the RWM to promote efficient viral translocation into the cochlea. Sendai virus expressing the green fluorescent protein reporter gene was detected throughout cochlear tissues following application combined with HA pretreatment. Quantitative analysis revealed that maximum expression was reached 3 days after treatment. The efficiency of transgene expression was several 100-fold greater with HA pretreatment than that without. Furthermore, unlike the conventional intracochlear delivery methods, this approach did not cause hearing loss. These findings reveal the potential utility of gene therapy with Sendai virus and HA for treatment of sensorineural hearing loss.
authors.affiliation: Department of Otolaryngology, Head and Neck Surgery, National Defense Medical College, Saitama, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kurioka
authors.affiliation: Department of Otolaryngology, Head and Neck Surgery, National Defense Medical College, Saitama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Mizutari
authors.affiliation: Department of Otolaryngology, Head and Neck Surgery, National Defense Medical College, Saitama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Niwa
authors.affiliation: Department of Otolaryngology, Head and Neck Surgery, National Defense Medical College, Saitama, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Fukumori
authors.affiliation: DNAVEC Corporation, Ibaraki, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Inoue
authors.affiliation: DNAVEC Corporation, Ibaraki, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Hasegawa
authors.affiliation: Department of Otolaryngology, Head and Neck Surgery, National Defense Medical College, Saitama, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Shiotani
mesh_terms: D000818:Animals; D003051:Cochlea / Q000378:metabolism*; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D006168:Guinea Pigs; D006319:Hearing Loss, Sensorineural / Q000628:therapy; D006820:Hyaluronic Acid / Q000494:pharmacology*; D012405:Round Window, Ear / Q000378:metabolism*; D029082:Sendai virus / Q000235:genetics*; D014162:Transfection / Q000379:methods*
chemical_list: D006820:Hyaluronic Acid